3.0.0 7537 2023-01-11T13:45:59Z 2023-01-11T13:45:59Z House HR 2020-07-09 116 [Congressional Record Volume 166, Number 124 (Thursday, July 9, 2020)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. KELLY of Pennsylvania:H.R. 7537.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8 of the US constitution. [Page H2369][Page H3077]]]> hswm00 Ways and Means Committee House Standing hswm02 Health Subcommittee Referred to 2020-07-09T13:46:10Z Referred to 2020-07-09T18:08:40Z Commitment to Defeat the Virus and Keep America Healthy Act 116 14 HR 2020-11-02 Referred to the Subcommittee on Railroads, Pipelines, and Hazardous Materials. Related bill CRS 2020-07-09 Referred to the House Committee on Ways and Means. IntroReferral H11100 2 House floor actions hswm00 Ways and Means Committee 2020-07-09 hswm02 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2020-07-09 Introduced in House IntroReferral Intro-H 9 Library of Congress 2020-07-09 Introduced in House IntroReferral 1000 9 Library of Congress K000376 Rep. Kelly, Mike [R-PA-16] Mike Kelly R PA 16 N Taxation Accounting and auditing Advanced technology and technological innovations Business investment and capital Income tax credits Infectious and parasitic diseases Medical research Small business Tax administration and collection, taxpayers Taxation 00 2020-07-09 Introduced in House 2021-05-25T14:15:06Z Infectious Disease Therapies Research and Innovation Act of 2020

This bill exempts from the definition of passive activity, for purposes of the passive loss tax rules, any qualified medical research activity of a specified medical research small business pass-thru entity.

The bill defines specified medical research small business pass-thru entity as any domestic pass-thru entity if more than 80% of such entity's expenditures on research are paid or incurred in connection with qualified medical research activities and the gross receipts of such entity for the taxable year are less than $1 million.

]]> Infectious Disease Therapies Research and Innovation Act of 2020 Display Title Infectious Disease Therapies Research and Innovation Act of 2020 Official Title as Introduced To amend the Internal Revenue Code of 1986 to provide an exception from the passive loss rules for investments in specified medical research small business pass-thru entities. Introduced in House IH Short Title(s) as Introduced Infectious Disease Therapies Research and Innovation Act of 2020 Introduced in House IH Introduced in House 2020-07-09T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-116hr7537ih/xml/BILLS-116hr7537ih.xml 2020-07-09 Referred to the House Committee on Ways and Means. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.